-
Penny Stock 5
Osteotech (OSTE)The baby boomers are aging, and yet they want to remain active. That bodes well for Osteotech (OSTE),
a maker of biologic products for orthopedic and spinal surgeons.Shares of OSTE are up 70% since December, and according to analysts who follow OSTE, the stock has much more upside as profits
are expected to come in 2010. Last quarter, OSTE lost 10 cents per share, and even though analysts expected a smaller loss, OSTE’s
share price held up well given future expectations.But the past is the past, and demographics being as they are, profits should be forthcoming in coming years. OSTE has the potential
to reach double-digit figures in a very short period of time. OSTE represented the high risk, high reward opportunity perfect for those
interested in penny stocks.Related Articles:
-
- ADVERTISEMENT
- Most Popular
- Top 10 Dow Dividend Stocks
See AllCompany Dividend Yield 1 AT&T (T) 5.8% 2 Verizon (VZ) 5.0% 3 Merck (MRK) 4.5% 4 Pfizer (PFE) 4.0% - Markets
- Partners







Comments are currently unavailable. Please check back soon.